In our study, the expression of LINC00641 had a positive correlation with the OS of glioma patients, and the expression of LINC00641 was significantly higher in normal astrocytes than in glioma cells, which supported the idea that LINC00641 was a protective factor for glioma. Here, LINC00641 is linked to central nervous system cancer.